Related by context. All words. (Click for frequent words.) 76 occlusion CRVO 75 acute peripheral arterial 72 macular edema secondary 72 central retinal vein 72 Intravitreal 71 acetonide FA 71 Diabetic Macular Edema DME 71 Phase 2b Clinical Trial 71 occlusion PAO 70 Investigational Treatment 70 Meets Primary Endpoint 70 diabetic macular edema DME 70 EVIZON TM 70 Neovascular 70 EVIZON ™ 69 Neovascularization 69 catheter occlusion 69 Diabetic Macular Edema 69 delivers fluocinolone acetonide FA 69 Pooled Analysis 69 Demonstrates Efficacy 69 pathologic myopia 69 RHEO 69 FDA Approvals 69 Phase 2a Clinical Trial 69 Chronic Sinusitis 69 Myoblast 68 Hormone Refractory Prostate Cancer 68 Dupuytren Disease 68 Neovascular AMD 68 esophageal candidiasis 68 Peripheral Arterial 68 Oral Fingolimod 68 branch retinal vein 68 Anti VEGF 68 retinal vein occlusion induced 68 choroidal neovascularization 68 Phase Ib Clinical Trial 68 Novel Oral 68 PEGylated Fab fragment 68 Study Evaluating 68 Vitrasert R 68 Non Alcoholic Steatohepatitis 68 Adjuvant Treatment 68 Initiates Clinical Trial 68 toenail onychomycosis 68 CIMZIA TM certolizumab pegol 68 Completes Patient Enrollment 67 cheilitis 67 Acute Ischemic Stroke 67 Neovascular Age Related Macular 67 Adjunctive 67 Elagolix 67 Pivotal Phase III 67 Xyfid TM 67 chronic thromboembolic pulmonary 67 retinal vein occlusion RVO 67 Tezampanel 67 induced macular edema 67 CRVO 67 neovascular form 67 Systemic Sclerosis 67 complement inhibitor eculizumab 67 vapreotide acetate 67 atypical Hemolytic Uremic Syndrome 67 Frozen Shoulder syndrome Adhesive 67 Phase 2b Trial 67 Squalamine 67 NASH Huntington 67 Placebo Controlled Study 67 Overactive Bladder 67 Metastatic Melanoma 67 Microplasmin 67 Pivotal Phase 67 Ranibizumab 67 Tyrosine Kinase Inhibitor 67 Occlusive Disease 67 Prospective Randomized 67 bullous 67 Clinical Trial Results 67 Patients Undergoing 67 Left Ventricular 67 metastatic malignant 67 Patients Treated With 67 Intravitreal injections 67 Diabetic Neuropathy 67 Phase III Pivotal 67 Lupus Nephritis 67 erosive gastritis 67 choroidal neovascularization CNV 67 Rheumatoid 67 lexidronam injection 67 Diabetic Retinopathy 67 Patients Receiving 67 Patient Enrollment 67 Non Alcoholic Fatty 67 dual endothelin receptor antagonist 67 Chronic Renal Failure 66 Phase IIb Clinical Trial 66 Prolongs Survival 66 Phase IIb Trial 66 ribavirin Copegus ® 66 familial amyloidotic polyneuropathy FAP 66 AMD diabetic retinopathy 66 Diabetic Nephropathy 66 PEGINTRON TM 66 Clinical Trial Evaluating 66 Completes Enrollment 66 NDA Submission 66 nephropathic cystinosis 66 Granted Orphan Drug 66 myelodysplastic myeloproliferative diseases 66 Complicated Skin 66 Atypical Hemolytic Uremic Syndrome 66 ocular angiogenesis 66 diarrhea predominant irritable 66 Initiate Phase 66 Pafuramidine 66 Syncria R 66 Receives Orphan Drug Designation 66 diarrhea fatigue asthenia 66 Angioedema 66 neovascular 66 Acute Exacerbations 66 Ophena TM 66 Secondary Hyperparathyroidism 66 Dose Ranging Study 66 anterior uveitis 66 squalamine 66 Refractory Angina 66 Randomized Phase 66 Phase III Clinical Trial 66 Bepreve TM 66 Treating Chronic 66 Randomized Double blind 66 Demonstrates Positive 66 vaginal candidiasis 66 disease GERD 66 Adjunctive Therapy 66 Initiated Phase 66 Improves Outcomes 66 Myelodysplastic Syndrome MDS 66 ocular disorders 66 Pivotal Trial 66 Phase 2b Study 66 Hepatic Encephalopathy 66 Advanced Melanoma 66 generation purine nucleoside 66 Benign Prostatic Hyperplasia 66 treat benign prostatic 66 Iluvien ® 66 subfoveal choroidal neovascularization 66 oral prodrug 66 Personalized Immunotherapy 66 Orthostatic Hypotension 65 OMNARIS HFA 65 Placebo Controlled 65 Benign Prostatic Hyperplasia BPH 65 Hypoactive Sexual Desire Disorder 65 iSONEP ™ 65 oropharyngeal candidiasis OPC 65 diabetic macular edema 65 Shows Statistically Significant 65 ocular inflammation 65 See CLINICAL PHARMACOLOGY 65 Phase 2a Trial 65 NAVISTAR R 65 headache nasopharyngitis 65 Catheter Ablation 65 erythematosus SLE 65 Squamous Cell Carcinoma 65 diarrhea vomiting rash 65 transthyretin TTR mediated amyloidosis 65 homozygous familial hypercholesterolemia 65 ELADUR ™ 65 SinuNase TM 65 Bronchiectasis 65 Disease IBD 65 II Clinical Trial 65 posterior uveitis 65 molecular imaging radiopharmaceutical 65 hypertrichosis occurred 65 opioid induced bowel dysfunction 65 Relapsing Multiple Sclerosis 65 Safinamide 65 vitreous floaters 65 First Patient Dosed 65 AIR2 Trial 65 Files IND 65 peripheral arterial occlusive disease 65 ST Elevation Myocardial 65 Retinopathy 65 hyperphenylalaninemia HPA due 65 Diabetic Foot Ulcer 65 ALN HPN 65 refractory gout 65 Inhaled Corticosteroids 65 neovascular age 65 Drug Candidate 65 glaucoma diabetic retinopathy 65 Efficacy Trial 65 Initiates Phase II 65 aneurysms AAA 65 Oral Spray 65 mGluR5 negative 65 overactive bladder syndrome 65 methylnaltrexone bromide 65 Controlled Study 65 novel VDA molecule 65 bone marrow reticulin deposition 65 Trial Evaluating 65 Cancer Cachexia 65 EVIZON TM squalamine lactate 65 Myelodysplastic Syndromes 65 Primary Hypercholesterolemia 65 Zemiva ™ 65 Thromboembolic 65 EVIZON 65 TLK# 65 atypical hemolytic uremic syndrome 65 CYT# potent vascular disrupting 65 ara C 65 R Saizen R 65 Panzem R 65 Vertebral Compression Fractures 65 fosbretabulin 65 Kuvan R 65 J Am Coll 65 Leber Hereditary Optic Neuropathy 65 selective phosphodiesterase 65 dependent kinase inhibitor 64 Soft Tissue Sarcoma 64 sapropterin dihydrochloride 64 choroidal neovascularisation 64 macular degeneration diabetic retinopathy 64 Initiate Clinical Trial 64 geographic atrophy 64 Demonstrates Sustained 64 essential thrombocythemia ET 64 Pediatric Patients 64 Acute Renal Failure 64 sapropterin dihydrochloride Tablets 64 prokinetic agent 64 refractory chronic lymphocytic 64 Intracranial 64 Intravascular 64 arthritis PsA 64 treat dysmenorrhea 64 Intracranial Aneurysms 64 TNF Tumor Necrosis Factor 64 Phase IIa Clinical Trial 64 Double Blind Placebo 64 Thiazolidinediones 64 2 methoxyestradiol 64 INCB# [003] 64 Preclinical Efficacy 64 Fungal Infections 64 STELARA TM 64 Transdermal Patch 64 vitreoretinal disorders 64 IL# PE#QQR 64 Investigational Oral 64 elevated intraocular pressure 64 Inhalation Solution 64 RNAi Therapeutic 64 Refractory Hodgkin Lymphoma 64 Relapsed Refractory 64 Heart Failure Patients 64 Prophylactic Treatment 64 Ranolazine 64 systemic juvenile idiopathic 64 Percutaneous Tibial Nerve Stimulation 64 Knee Osteoarthritis 64 Adjuvant Chemotherapy 64 Novel Inhibitor 64 Hedgehog Pathway Inhibitor 64 Critical Limb Ischemia CLI 64 REMINDER ORLive Presents 64 Denufosol 64 PresbyLens ® 64 pegaptanib 64 Clinical Outcome 64 Aflibercept 64 Phase III Trial 64 brand ciclesonide HFA 64 treat chronic sinusitis 64 Successfully Completes Phase 64 CTAP# 64 herpetic keratitis 64 octreotide implant 64 cromolyn sodium 64 Pulmonary Arterial Hypertension 64 Single Dose 64 See WARNINGS 64 R lenalidomide 64 Aneurysm Repair 64 Naive Patients 64 kidney urologic 64 retinal vein occlusion 64 Hormone Receptor Positive 64 BCG refractory carcinoma 64 Metastatic Colorectal Cancer 64 First Patient Enrolled 64 INS# [001] 64 metastatic colorectal carcinoma 64 Mouse Model 64 myocardial infarction ventricular fibrillation 64 ANCA associated 64 Efficacy Results 64 severe gastroparesis 64 Severe Sepsis 64 PEG uricase 64 Initiates Phase III 64 Regenerative Cells 64 conjunctival hyperemia 64 Oral Mucositis 64 recurrent glioblastoma multiforme 64 failure ADHF 64 Cerebril TM 64 Pharmacokinetics PK 64 Hepatocellular Carcinoma 64 headache abdominal pain 64 Mg Usa 64 Randomized Placebo controlled 64 Inflammatory Diseases 64 Inhalation Aerosol 64 Elderly Patients 64 lupus erythematosus 64 Randomized Clinical Trial 64 Angiotensin Converting Enzyme 64 TRANSFORMS 64 Successfully Treats 64 selective androgen receptor modulator 64 Malignant Melanoma 64 Demonstrates Significant 64 oral nucleoside analogue 64 purpura ITP 64 imipramine Tofranil 64 alfa 2a 64 GW# [003] 64 Loceryl ® 64 Hypertrophic 64 Ischemic 64 Thrombotic 64 Patients Treated 64 systemic anaplastic large 64 constipation OIC 64 acyclovir Lauriad R 64 Iluvien TM 64 ocular inflammatory 63 symptomatic benign prostatic 63 Nebulized 63 LymphoStat B belimumab 63 keloid scarring 63 Coronary Artery Bypass Graft 63 MIVI III 63 Limb Ischemia 63 Initiates Enrollment 63 Oral Calcitonin 63 Polymerase Inhibitor 63 overactive bladder AA# 63 Left Ventricular Hypertrophy 63 MKC# MKC# PP 63 verteporfin 63 hemodynamically significant 63 evaluating picoplatin 63 Solazed TM 63 hormone refractory metastatic prostate 63 unresectable tumors 63 Long Term Efficacy 63 Arteriovenous 63 Idiopathic Pulmonary Fibrosis 63 aldehyde dehydrogenase ALDH2 deficiency 63 Biolimus A9 63 NAVISTAR ® THERMOCOOL ® 63 NAGS deficiency 63 albiglutide currently 63 Shows Promise Against 63 de novo kidney transplant 63 Kamada AAT 63 ALN PCS 63 Chronic Bronchitis 63 ALN TTR 63 INSPIRE Trial Phase III 63 riociguat 63 ergot derivatives 63 Orally administered 63 systemic lupus erythematosus psoriasis 63 topically applied SEPA 63 Overactive Bladder OAB 63 Phase III Pivotal Trial 63 Eculizumab 63 Stomatitis 63 acute GvHD 63 phase IIb clinical 63 Dupuytren Contracture 63 Testosterone MDTS R 63 Controlled Trial 63 Catheter Associated 63 Leber Congenital Amaurosis LCA 63 nonarteritic anterior ischemic optic 63 idiopathic thrombocytopenic purpura ITP 63 Pivotal Clinical Trial 63 Replacement Therapy 63 Renal Function 63 ORENCIA ® 63 dihydrochloride Tablets 63 dasatinib Sprycel ® 63 relapsing remitting MS RRMS 63 Prematurity ROP 63 benign prostatic hypertrophy BPH 63 ALVESCO ® 63 steroid refractory ulcerative 63 neutropenia thrombocytopenia 63 Patency 63 Subgroup Analysis 63 photocoagulation 63 Mycophenolate Mofetil 63 ORLive Presents 63 FDA APPROVES 63 ILUVIEN ® 63 BRIM2 63 Eluting Stent 63 pediatric Crohn disease 63 nausea vomiting fatigue 63 candesartan cilexetil 63 virus HCV protease inhibitor 63 Treatment Resistant 63 Initiate Phase III 63 hyperplasia BPH 63 Golimumab 63 Fondaparinux 63 Chronic HCV 63 endoluminal stent graft 63 refractory cutaneous T 63 % uracil topical 63 Ribavirin causes 63 phenylketonuria PKU developed 63 Pivotal Study 63 systemic fungal infections 63 Previously Treated 63 Phase IIIb 63 predominantly classic subfoveal 63 EnteroMedics proprietary neuroblocking technology 63 Renal Impairment 63 allosteric modulator NAM 63 TRANSDUR ™ 63 Neuropathic 63 Corneal Transplant 63 Mg Uk 63 ischemic mitral regurgitation 63 Bazedoxifene 63 Clostridium difficile Infection 63 Kuvan TM sapropterin 63 situ CIS 63 Treated Patients 63 Cypher Sirolimus 63 Chronic Myeloid Leukemia 63 Late Breaker 63 Infarct 63 evaluating mipomersen 63 Multicenter Randomized Double 63 Geographic Atrophy 63 Acute Treatment 63 Zenvia ™ 63 Left Ventricular Dysfunction 63 Albuferon TM 63 sitaxsentan 63 Gastrointestinal Stromal Tumors 63 Acute Myocardial Infarction 63 Combination REOLYSIN R 63 Randomised 63 Entereg R 63 ® lenalidomide 63 DDP# 63 Investigational Compound 63 nausea vomiting headache 63 Keratitis 63 Submits NDA 63 Myelofibrosis 63 metformin accumulation 63 Subtypes 63 Acute Heart Failure 63 trial evaluating PRX# 63 Rheumatoid Arthritis Patients 63 Intravenous Formulation 63 Zorbtive TM 63 Parathyroid Hormone 63 LENALIDOMIDE 63 IN PATIENTS WITH 63 External Beam 63 Wafer polifeprosan 63 MetroGel 63 Hypertrophy 63 Shows Efficacy 63 Hsp# Inhibitor 63 invasive candidiasis 63 Maven Semantic 63 polycythemia vera essential thrombocythemia 63 superficial femoral 63 Microwave Ablation System 63 Initiates Clinical 63 systemic hypotension 63 VIVITROL ® 63 Follicular Lymphoma 63 dextromethorphan quinidine 63 ocular formulation 63 Novel Compound 63 proliferative retinopathy 63 Amgen Neulasta R 63 Plaque Psoriasis 63 haematologic 63 Surgical Treatment 63 MKC# MT 63 pericardial effusions 63 sirtuin inhibitor program 63 Stereotactic Radiosurgery 63 orally inhaled migraine 63 Prolacria 63 BENLYSTA TM 63 topical gel formulation 63 Vitrasert ® 63 nephropathic cystinosis cystinosis 63 interferon gamma 1b 63 vWD 63 orally administered inhibitor 63 iSONEP TM 63 FOLOTYN ® 63 Nonsurgical 63 Achieves Primary Endpoint 63 metabolic alkalosis 63 Slow Progression 62 Aliskiren 62 denufosol tetrasodium 62 Clinical Efficacy 62 Carcinomas 62 including acne photodamage 62 Ozarelix 62 stable angina pectoris 62 beta 1a 62 Liprotamase 62 neurogenic bladder 62 Novel Treatments 62 Myocardial Infarction Study 62 postoperative ileus POI 62 Advanced Renal Cell 62 Bucindolol 62 pralatrexate injection folate analogue 62 Randomized Double Blind 62 Glatiramer Acetate 62 Cutaneous T 62 formerly LymphoStat B 62 miconazole Lauriad ® 62 QLT# 62 Ischaemic 62 Enlarged Prostate 62 Deforolimus 62 arsenic trioxide injection 62 Gliadel R 62 PAOD 62 Telithromycin 62 Serostim ® 62 Desvenlafaxine Succinate 62 Methylnaltrexone 62 Bronchodilator 62 HCV Genotype 62 Chronic Hepatitis C 62 steroid refractory GvHD 62 SYN# 62 Non Invasive Treatment 62 PNP inhibitor 62 itraconazole Sporanox 62 J Clin 62 undergone cataract extraction 62 Topical Treatment 62 severe malignant osteopetrosis 62 Tolvaptan 62 immunocompetent patients 62 Immune Mediated 62 zonisamide SR 62 5 fluorouracil leucovorin 62 Renal Anemia 62 Brentuximab Vedotin SGN 62 Schizophrenia Treatment 62 Lenocta TM 62 Major Depressive Disorder MDD 62 Ozurdex 62 Effectively Treats 62 liposome injection 62 orally administered synthetic retinoid 62 Fibromyalgia Syndrome FMS 62 Valvular Heart Disease 62 Medoxomil 62 deep venous thromboses 62 targeted radiotherapeutic 62 Begins Dosing 62 choroidal vasculopathy 62 TELINTRA 62 Pericardial 62 Placebo Controlled Trial 62 non splenectomized 62 Seasonal Allergic Rhinitis 62 topically administered 62 systemic corticosteroid 62 Phase #b/#a clinical 62 primary dysmenorrhea 62 proliferative diabetic retinopathy 62 iobenguane 62 Demonstrate Significant 62 phenylketonuria PKU 62 immuno inflammatory diseases 62 Hypertensive Patients 62 Solazed ™ 62 Increased Mortality 62 MR Angiography 62 R roscovitine CDK cyclin 62 candidate XP# 62 phase IIb study 62 Wet AMD 62 electrolyte abnormalities 62 chronic renal disease 62 Renal Artery 62 J Am Acad 62 oral beclomethasone dipropionate 62 Aurora Kinase 62 Chronic Heart Failure 62 relapsing multiple sclerosis 62 Progenitor Cells 62 anti angiogenic agent 62 glaucoma macular degeneration 62 Ovitrelle R Serostim 62 oral antidiabetic medication 62 oral dual endothelin 62 medically refractory 62 Hypercholesterolemia 62 receptor tyrosine kinase inhibitor 62 By JENNIFER LEARN 62 Simulect 62 Physician Insights 62 AA Amyloidosis 62 Combination Treatment 62 Arterial Disease 62 Critical Limb Ischemia 62 tolterodine ER 62 personalized cellular immunotherapy 62 Acute Myocardial 62 Autologous Stem Cell Transplantation 62 post herpetic 62 Age Related Macular 62 cell lymphoma CTCL 62 Interferon Beta 62 Natalizumab 62 erlotinib Tarceva ® 62 Slows Progression 62 myelofibrosis polycythemia vera 62 hypereosinophilic syndrome 62 Pulmonary Arterial Hypertension PAH 62 opioid induced constipation OIC 62 Immunomodulatory 62 Sevelamer 62 IND Application 62 cysteamine bitartrate 62 FUSILEV enhances 62 inhibitor RG# 62 Selective Cardiac Myosin Activator 62 dilated cardiomyopathy DCM 62 Romidepsin 62 Lennox Gastaut Syndrome 62 Heterozygous Familial Hypercholesterolemia 62 pancreatic insufficiency 62 either acutely decompensated 62 Immunotherapeutic 62 nimodipine 62 Diabetic Foot Ulcers 62 treating abdominal aortic 62 recurrent sinusitis 62 Pharmacokinetic Study 62 Cimzia ® certolizumab pegol 62 Chemokine Receptor 62 PEGylated anti 62 Relapsing Remitting Multiple Sclerosis 62 receiving XGEVA 62 valsartan amlodipine 62 IND Filing 62 dizziness headache nausea 62 Venous Thromboembolism 62 debilitating complication 62 REPRONEX ® menotropins 62 EXPAREL TM 62 Alfimeprase 62 Host Disease 62 Lubiprostone 62 AVAPRO 62 Hemorrhagic 62 INTEGRILIN R 62 Preclinical Data 62 DIRECT Trial 62 Endologix Powerlink System 62 Novel Mechanism 62 Advanced Colorectal Cancer 62 Opterone R 62 STRIDE PD 62 Lymphocytic 62 ® adefovir dipivoxil 62 Phase 1b clinical trials 62 reduce serum phosphate 62 postherpetic neuralgia PHN 62 Stent Implantation 62 Dose Escalation 62 Motexafin Gadolinium 62 erythematosus 62 alpha1 antitrypsin deficiency 62 morphometric vertebral fractures 62 CCX# B 62 TELINTRA R 62 severe oral mucositis 62 cough dyspnea 62 orally inhaled 62 interferon alpha IFN 62 assessing T DM1 62 venous stasis ulcers 62 Tasimelteon 62 Renal Cell Carcinoma 62 Investigational Agent 62 primary hyperparathyroidism 62 related Macular Degeneration 62 Is Well Tolerated 62 lucinactant 62 Minimally Invasive Treatment 62 unresectable HCC 62 acute PAO 62 unresectable stage 62 cystic fibrosis chronic pancreatitis 62 albiglutide 62 ACE Inhibitors 62 Peginterferon 62 cytomegalovirus infection 62 ACTEMRA TM 62 Retisert TM 62 PENTASA 62 paroxysmal nocturnal hemoglobinuria 62 modified glutathione analog 62 Hyperlipidemia 62 Perceiva 62 pruritus rash 62 Stargardt Macular Dystrophy 62 severe hypercholesterolemia 62 sorafenib tablets 62 presumed ocular histoplasmosis 62 Drug Prevents 62 docetaxel Taxotere ® 62 Stent Restenosis 62 proliferator activated receptor 61 phase III isavuconazole 61 Ondansetron Injection USP 61 Zemiva TM 61 Anticancer Activity 61 Numoisyn Liquid 61 KL4 Surfactant 61 Phase 2a Study 61 migraines neurorehabilitation 61 Chronic Hepatitis B 61 Relapsed Multiple Myeloma 61 pseudobulbar affect PBA 61 CIMZIA R 61 Gel repository corticotropin injection 61 GAMMAGARD 61 Prodarsan R 61 gastro esophageal reflux 61 Metastatic Prostate Cancer 61 superficial basal cell carcinoma 61 adult periodontitis 61 Dosa suffers 61 gastrointestinal stromal tumors GIST 61 Randomized Study 61 IBS C 61 Etanercept 61 diabetic gastroparesis 61 Peyronie Disease 61 gastrointestinal GI perforation 61 treat opioid induced 61 Seliciclib CYC# 61 Acute Lung 61 eosinophilic asthma 61 sevelamer carbonate 61 Philadelphia Chromosome Positive 61 iGVHD 61 Sezary syndrome 61 Tacrolimus 61 oral anti arrhythmic 61 Vaccine Candidate 61 Cell Lymphoma 61 Antitumor Activity 61 Abrupt discontinuation 61 occlusive disease 61 salmeterol fluticasone 61 steroid refractory 61 Platinol ® 61 ADL# novel 61 nicardipine 61 Aryplase 61 Aortic Stenosis 61 interstitial pneumonitis 61 LUMINATE 61 Investigational Drug 61 Fibrin Pad 61 reflux esophagitis 61 Vascular Disrupting Agent 61 Metabolic Efficiency 61 Factor VIIa 61 Chronic Constipation 61 xerostomia secondary 61 symptomatic neurogenic orthostatic hypotension 61 investigational oral inhibitor 61 CINQUIL 61 rFVIIa 61 Urethral 61 mycosis fungoides 61 IIa Clinical Trial 61 Oral Cladribine 61 autoimmune uveitis 61 Myeloma Patients 61 Surgical Procedures 61 cell carcinoma RCC 61 neovascular diseases 61 carcinoid syndrome 61 sunitinib Sutent 61 Luveniq 61 integrin inhibitor 61 investigational pharmacologically unique 61 CTAP# Capsules 61 SUPPRELIN R LA 61 developing Bicifadine serotonin 61 Degarelix 61 Sapacitabine 61 invasive aspergillosis 61 neovascular wet age 61 Matrix Phase 2b 61 Phase IIb clinical trials 61 Randomized Evaluation 61 Presents Positive 61 Daclizumab 61 Decompensated Heart Failure 61 PDX pralatrexate 61 allogeneic hematopoietic cell 61 delta gamma agonist 61 arterial thrombosis 61 metastatic GIST 61 thalidomide Thalomid 61 receiving chemoradiation therapy 61 Cholesterol Lowering Drug 61 Growth Hormone Deficiency 61 Contrast Agent 61 Risk Stratification 61 Lucentis ranibizumab 61 neurogenic orthostatic hypotension 61 Xanafide 61 transplantation HCT 61 Liver Tumors 61 AzaSite TM 61 JAK2 Inhibitor 61 mecarbil 61 See CONTRAINDICATIONS 61 Clolar ® 61 Enzyme Replacement Therapy 61 Resistant Hypertension 61 AzaSite Plus 61 Pharmacodynamics 61 Venous Thrombosis 61 Tiotropium 61 ONCONASE R 61 post operative ileus 61 Retisert ® 61 Eisenmenger syndrome 61 AFREZZA TM 61 rALLy 61 Durezol TM 61 intravitreal injection 61 Elestrin ® 61 Patients Suffering 61 refractory recurrent 61 Antiviral Therapy 61 TRANSDUR ® 61 LHON 61 included neutropenia anemia 61 CCX# 61 including eniluracil ADH 61 mixed hyperlipidemia 61 Patient Outcomes 61 IMPACT DCM 61 Kuvan sapropterin dihydrochloride 61 Acute Bacterial Sinusitis ABS 61 Squamous 61 Cardiotoxicity 61 Testosterone MDTS ® 61 ziprasidone Geodon 61 Amphotericin B 61 fluvastatin Lescol 61 Malignant Glioma 61 EDEMA3 trial 61 Cardiac Resynchronization 61 MAGE A3 ASCI 61 Cannabinor 61 multicenter randomized placebo controlled 61 intranasal formulation 61 Crofelemer budesonide foam 61 infectious diseases autoimmune diseases 61 Entereg TM 61 metastatic neuroendocrine tumors 61 Preclinical Models 61 DURIN TM 61 Dasatinib 61 Nephrol 61 Cleviprex TM clevidipine 61 HYVISC R 61 exudative 61 relapsed MM 61 Myelodysplastic Syndrome 61 ANN INTERN MED 61 biliary tract cancer 61 chronic eosinophilic leukemia 61 Infusion Reactions Severe 61 Hosp Epidemiol 61 Inflammatory Arthritis 61 dihydrochloride 61 Pirfenidone 61 Unit Dose Budesonide 61 VICTOR E3 61 plus Copegus R 61 onabotulinumtoxinA 61 R#/MEM 61 Unigene nasal calcitonin 61 Liver Metastases 61 Multiple Myeloma MM 61 E1 INT TM 61 plasma kallikrein inhibitor 61 Antigen Specific 61 TO AVOID PREGNANCY WHILE 61 triamcinolone acetonide 61 Pulmonary Artery 61 descending thoracic 61 Diabetic Retinopathy DR 61 Familial Adenomatous Polyposis FAP 61 prescribed proton pump 61 idiopathic thrombocytopenic purpura 61 Bevasiranib 61 omega interferon 61 Intervention Effectiveness 61 Osteomyelitis 61 octreotide acetate 61 candidates Azedra 61 polyneuropathy HIV DSP 61 sublingual tablet 61 Infarction 61 Uterine Fibroid Embolization 61 inflammatory cardio metabolic 61 Kinase Inhibitor 61 Endarterectomy 61 VP# [004] 61 pain hypotension CVA 61 Viral Infections 61 GORE VIABAHN ® 61 RELOVAIR ™ 61 chemoradiation therapy 61 small molecule Hedgehog 61 6R BH4 61 Respiratory Distress 61 Multiple Myeloma Patients 61 non constipating irritable 61 CINTREDEKIN BESUDOTOX 61 Lupus nephritis 61 Pulmonary Embolism PE 61 Hepatitis C Genotype 61 AMEVIVE 61 underlying vasculopathy 61 Poster Presentations 61 Severe Asthma 61 glaucoma cataract 61 inhalation aerosol 61 Reduces Mortality 61 Traficet EN 61 Microvascular 61 TMS Therapy 61 Valsartan 61 Predict Risk 61 #mg/#mg 61 Cloretazine ® 61 PRN FDA Approves 61 Aggressive Reduction 61 Treatment Reduces 61 RhuDex 61 Treatment Naive Patients 61 Retisert 61 5 Fluorouracil 61 cetuximab Erbitux R 61 Adenoscan R 61 Metabolic Disease 61 Exacerbations 61 Glypromate